drugset / Trial / NCT03335033

New Technologies to Determine Carotid Plaque Vulnerability in Patients With Significant Carotid Plaques

NCT03335033

Phase 2 Completed 54 enrolled Mayo Clinic
Non-randomizedParallel-groupOpen-labelBasic science

Summary

The researchers are trying to determine if the characterization of "vulnerable" carotid artery plaques can be accomplished with ultrasound-based methods that look for vessels in the plaque and measure the plaque stiffness.

Timeline

Start
2017-11-15
Primary completion
2022-01-30
Completion
2022-01-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Lumason Diagnostic / imaging agent Intravenous

Indications